Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001398344-25-000563
Filing Date
2025-01-10
Accepted
2025-01-10 15:56:35
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 5402
  Complete submission text file 0001398344-25-000563.txt   7273
Mailing Address 360 S. ROSEMARY AVE SUITE 1420 WEST PALM BEACH FL 33401
Business Address 360 S. ROSEMARY AVE SUITE 1420 WEST PALM BEACH FL 33401 561-484-7185
RIVERNORTH CAPITAL MANAGEMENT, LLC (Filed by) CIK: 0001447578 (see all company filings)

EIN.: 271560688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A

Mailing Address 10900 NE 4TH STREET, SUITE 2300 BELLEVUE WA 98004
Business Address 10900 NE 4TH STREET, SUITE 2300 BELLEVUE WA 98004 425-635-7700
Bellevue Life Sciences Acquisition Corp. (Subject) CIK: 0001840425 (see all company filings)

EIN.: 845052822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-93996 | Film No.: 25522775
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)